Evaluation in alcohol use disorders – insights from the nalmefene experience
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation in alcohol use disorders – insights from the nalmefene experience
Authors
Keywords
-
Journal
BMC Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-17
DOI
10.1186/s12916-016-0664-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
- (2016) Niamh Fitzgerald et al. ADDICTION
- Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?
- (2016) Florian Naudet et al. ALCOHOL AND ALCOHOLISM
- The Cost-Effectiveness of the Integration of Nalmefene within the UK Healthcare System Treatment Pathway for Alcohol Dependence
- (2016) Philippe Laramée et al. ALCOHOL AND ALCOHOLISM
- The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective
- (2016) Thor-Henrik Brodtkorb et al. CNS DRUGS
- Recommendations of French Alcohol Society and European Federation of Addiction Societies
- (2016) Alain Braillon CNS Neuroscience & Therapeutics
- Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
- (2016) Michael Soyka EXPERT OPINION ON PHARMACOTHERAPY
- Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis
- (2016) M. Soyka et al. PHARMACOPSYCHIATRY
- Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?
- (2016) F. Naudet PHARMACOPSYCHIATRY
- Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine
- (2016) Michael Soyka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The European Medicines Agency is still too close to industry:
- (2016) Silvio Garattini BMJ-British Medical Journal
- The European Medicines Agency is still too close to industry:
- (2016) Silvio Garattini BMJ-British Medical Journal
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
- (2015) Kim Donoghue et al. ADDICTION
- Los Antagonistas de los Receptores Opioides en el Tratamiento del Alcoholismo
- (2015) Josep Guardia Serecigni Adicciones
- Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies
- (2015) Benjamin Rolland et al. CNS Neuroscience & Therapeutics
- Nalmefene: A Novel Drug for an Old Disorder
- (2015) Donatella Marazziti et al. CURRENT MEDICINAL CHEMISTRY
- Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
- (2015) Michael Roerecke et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
- (2015) Matt Stevenson et al. PHARMACOECONOMICS
- Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
- (2015) Clément Palpacuer et al. PLOS MEDICINE
- Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis
- (2015) Philippe Laramée et al. EBioMedicine
- The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
- (2015) Clément François et al. PLoS One
- Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials
- (2014) Katie Witkiewitz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- How to Use a Subgroup Analysis
- (2014) Xin Sun et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
- (2014) Wim van den Brink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
- (2014) P. Laramee et al. BMJ Open
- German evaluation says new drug for alcohol dependence is no better than old one
- (2014) N. Stafford BMJ-British Medical Journal
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
- (2013) W. van den Brink et al. ALCOHOL AND ALCOHOLISM
- Reduction of Drinking in Problem Drinkers and All-Cause Mortality
- (2013) J. Rehm et al. ALCOHOL AND ALCOHOLISM
- Naltrexone and Nalmefene: Any Meaningful Difference?
- (2013) Robert M. Swift BIOLOGICAL PSYCHIATRY
- A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
- (2013) Antoni Gual et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Mega-Trials for Blockbusters
- (2013) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduction of Alcohol Consumption and Subsequent Mortality in Alcohol Use Disorders
- (2013) Michael Roerecke et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Importance of Quality of Life in Patients with Alcohol Abuse and Dependence
- (2013) Chio Ugochukwu et al. HARVARD REVIEW OF PSYCHIATRY
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence
- (2010) James C. Garbutt CURRENT PHARMACEUTICAL DESIGN
- Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non-Natives Residing in Rural Settings: A Randomized Controlled Trial
- (2008) Stephanie S. OMalley et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started